BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26221316)

  • 21. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
    Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
    Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.
    Yu LY; Hu KC; Liu CJ; Hung CL; Bair MJ; Chen MJ; Wang HY; Wu MS; Shih SC; Liu CC
    Medicine (Baltimore); 2019 Mar; 98(9):e14672. PubMed ID: 30817593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
    Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease and carotid atherosclerosis in children.
    Pacifico L; Cantisani V; Ricci P; Osborn JF; Schiavo E; Anania C; Ferrara E; Dvisic G; Chiesa C
    Pediatr Res; 2008 Apr; 63(4):423-7. PubMed ID: 18356751
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Zhao W; Mori H; Tomiga Y; Tanaka K; Perveen R; Mine K; Inadomi C; Yoshioka W; Kubotsu Y; Isoda H; Kuwashiro T; Oeda S; Akiyama T; Zhao Y; Ozaki I; Nagafuchi S; Kawaguchi A; Aishima S; Anzai K; Takahashi H
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
    Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
    BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta-analysis.
    Zhou YY; Zhou XD; Wu SJ; Fan DH; Van Poucke S; Chen YP; Fu SW; Zheng MH
    Hepatol Commun; 2018 Apr; 2(4):376-392. PubMed ID: 29619417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Zenari L; Zoppini G; Falezza G
    J Endocrinol Invest; 2006 Jan; 29(1):55-60. PubMed ID: 16553034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.
    Lankarani KB; Mahmoodi M; Lotfi M; Zamiri N; Heydari ST; Ghaffarpasand F; Fallahzadeh MK; Babaeinejad M; Maharlouei N; Mirzaee O; Geramizadeh B; Peymani P
    Korean J Gastroenterol; 2013 Dec; 62(6):344-51. PubMed ID: 24365733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
    Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
    Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
    Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.
    Tang ASP; Chan KE; Quek J; Xiao J; Tay P; Teng M; Lee KS; Lin SY; Myint MZ; Tan B; Sharma VK; Tan DJH; Lim WH; Kaewdech A; Huang D; Chew NW; Siddiqui MS; Sanyal AJ; Muthiah M; Ng CH
    Clin Mol Hepatol; 2022 Jul; 28(3):483-496. PubMed ID: 35232007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gwak GY; Cho J; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW
    Medicine (Baltimore); 2016 Jan; 95(3):e2578. PubMed ID: 26817915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Serum Gamma-glutamyl Transpeptidase Levels and Fatty Liver Strongly Predict the Presence of Carotid Plaque.
    Toshikuni N; Asaji T; Nakanishi Y; Nagasawa SY; Uenishi H; Tsutsumi M
    J Atheroscler Thromb; 2015; 22(10):1051-60. PubMed ID: 25891209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.
    Ampuero J; Gallego-Durán R; Romero-Gómez M
    Rev Esp Enferm Dig; 2015 Jan; 107(1):10-6. PubMed ID: 25603326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between non-alcoholic fatty liver disease and ischemic stroke.
    Moshayedi H; Ahrabi R; Mardani A; Sadigetegad S; Farhudi M
    Iran J Neurol; 2014 Jul; 13(3):144-8. PubMed ID: 25422733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study.
    Castaldo L; Laguzzi F; Strawbridge RJ; Baldassarre D; Veglia F; Vigo L; Tremoli E; de Faire U; Eriksson P; Smit AJ; Aubrecht J; Leander K; Pirro M; Giral P; Ritieni A; Di Minno G; Mälarstig A; Gigante B
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33105679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease.
    Mishra S; Yadav D; Gupta M; Mishra H; Sharma P
    Indian J Clin Biochem; 2013 Jan; 28(1):79-83. PubMed ID: 24381427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
    Wang CC; Lin SK; Tseng YF; Hsu CS; Tseng TC; Lin HH; Wang LY; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1411-6. PubMed ID: 19702910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.